Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Wednesday, March 16, 2022
FDA | Center for Drug Evaluation and Research
The Food and Drug Administration is advising consumers not to purchase or use Artri Ajo King, a product promoted and sold for joint pain and arthritis on various websites and possibly in some retail stores.
FDA laboratory analysis confirmed that Artri Ajo King contains diclofenac not listed on the product label. Diclofenac is a non-steroidal anti-inflammatory drug (commonly referred to as NSAIDs). NSAIDs may cause increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration, and fatal perforation of the stomach and intestines. This hidden drug ingredient may also interact with other medications and significantly increase the risk of adverse events, particularly when consumers use multiple NSAID-containing products. Consumers should immediately consult a health care professional if they are experiencing any side effects.